Stay updated on Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial
Sign up to get notified when there's something new on the Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial page.

Latest updates to the Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial page
- Check2 days agoChange DetectedThe page no longer includes the primary disease term 'Multiple myeloma' and removes the 'related topics' and 'MedlinePlus Genetics' sections. This reduces the explicit disease context and access to related resources for the study.SummaryDifference0.2%

- Check9 days agoChange DetectedRevision updated to v3.5.0 and related topics such as MedlinePlus Genetics have been added, and 'Multiple myeloma' is listed as a topic.SummaryDifference0.2%

- Check17 days agoChange DetectedRemoved the related topics entries for Multiple myeloma and MedlinePlus Genetics from the study page. Core study information and eligibility criteria remain unchanged.SummaryDifference0.2%

- Check24 days agoChange DetectedRevision metadata updated: added v3.4.3 and removed v3.4.2.SummaryDifference0.1%

- Check31 days agoChange DetectedAdded related topics: Multiple Myeloma and MedlinePlus Genetics to the page to improve access to contextual information.SummaryDifference0.2%

- Check45 days agoChange Detected- Deleted the related topics entry for 'Multiple myeloma' and MedlinePlus Genetics; core trial details and page structure remain unchanged.SummaryDifference0.2%

Stay in the know with updates to Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial page.